Lost Ground: Cancer Screening in the COVID-19 Era
A pandemic-related drop in cancer diagnoses could spell long-term trouble for patients and providers.
Top of the News-dtet
Simplifying At-Home Tests with AI
A new assay uses AI-optimized enzymes to simplify and increase the accuracy of rapid pathogen detection.
Investigating the Cause of the 2022 Severe Acute Hepatitis Outbreak in Children
AAV2 virus detected with metagenomics, TE sequencing, and PCR in non-A–E hepatitis cases from two cohorts in Scotland/the UK and the US.
Special Report: What Next for COVID-19 Tests?
An overview of what will happen to the COVID-19 tests issued via EUA once the public health emergency ends on May 11.
SARS-CoV-2 Saliva Testing Gains Traction
Saliva testing for the virus that causes COVID-19 is gaining acceptance in both the scientific community and US market.
Genomic Biomarker Tests Endorsed for Early Prostate Cancer Management
Revised guidelines from the American Urological Association support limited use of the tests for certain prostate cancer patients.
Digital Health Care Raising Money at Record Pace, with Software & Mental Health Leading the Way
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
CDC Knowingly Sent Flawed COVID-19 Test Kits to Public Laboratories in Early Days of Crisis
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
CDC Withdraws Recommendation of Testing for Asymptomatic Individuals After Close Exposure to COVID-19
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Major Insurer Claims It Has No Obligation to Pay for Pooled COVID-19 Testing
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Quest Test Gets First FDA Green Light for Sample Pooling to Detect SARS-CoV-2
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Top of the News: CMS Issues New Guidance for Laboratories Performing Coronavirus Testing
On Feb. 4, the Food and Drug Administration (FDA) granted emergency use authorization (EUA) clearance for the first test approved in the US for detecting the novel coronavirus. Developed by the US Centers for Disease Control and Prevention (CDC) using sequencing...
Agency to Use EUA Pathway to Clear New Coronavirus Detection Tests
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
